Development of influenza A antivirals
The present invention includes compositions, methods and systems to isolate and characterize novel antiviral agents by contacting the antiviral agent with the F2F3 zinc fingers of a CPSF30 protein and an Influenza A NS1A protein; and determining whether the binding between the CPSF30 protein and the...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
22.11.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention includes compositions, methods and systems to isolate and characterize novel antiviral agents by contacting the antiviral agent with the F2F3 zinc fingers of a CPSF30 protein and an Influenza A NS1A protein; and determining whether the binding between the CPSF30 protein and the Influenza A NS1A protein is reduced. |
---|---|
Bibliography: | Application Number: US20090554767 |